• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Asxl1 缺失改变骨髓基质细胞的自我更新和细胞命运,导致小鼠出现 Bohring-Opitz 样综合征。

Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice.

机构信息

Department of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; Key Laboratory of Chemical Safety and Health, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing 100050, China.

出版信息

Stem Cell Reports. 2016 Jun 14;6(6):914-925. doi: 10.1016/j.stemcr.2016.04.013. Epub 2016 May 26.

DOI:10.1016/j.stemcr.2016.04.013
PMID:27237378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4911496/
Abstract

De novo ASXL1 mutations are found in patients with Bohring-Opitz syndrome, a disease with severe developmental defects and early childhood mortality. The underlying pathologic mechanisms remain largely unknown. Using Asxl1-targeted murine models, we found that Asxl1 global loss as well as conditional deletion in osteoblasts and their progenitors led to significant bone loss and a markedly decreased number of bone marrow stromal cells (BMSCs) compared with wild-type littermates. Asxl1(-/-) BMSCs displayed impaired self-renewal and skewed differentiation, away from osteoblasts and favoring adipocytes. RNA-sequencing analysis revealed altered expression of genes involved in cell proliferation, skeletal development, and morphogenesis. Furthermore, gene set enrichment analysis showed decreased expression of stem cell self-renewal gene signature, suggesting a role of Asxl1 in regulating the stemness of BMSCs. Importantly, re-introduction of Asxl1 normalized NANOG and OCT4 expression and restored the self-renewal capacity of Asxl1(-/-) BMSCs. Our study unveils a pivotal role of ASXL1 in the maintenance of BMSC functions and skeletal development.

摘要

ASXL1 基因突变可在 Bohring-Opitz 综合征患者中检出,该病具有严重的发育缺陷和婴幼儿早期死亡率。但其潜在的病理机制在很大程度上仍不清楚。通过使用 Asxl1 靶向的小鼠模型,我们发现与野生型同窝仔鼠相比,Asxl1 全局缺失以及成骨细胞及其前体细胞中的条件性缺失导致明显的骨丢失和骨髓基质细胞(BMSCs)数量显著减少。Asxl1(-/-) BMSCs 表现出自我更新受损和分化偏倚,远离成骨细胞,更倾向于脂肪细胞。RNA 测序分析显示,涉及细胞增殖、骨骼发育和形态发生的基因表达发生改变。此外,基因集富集分析显示,干细胞自我更新基因特征的表达降低,表明 ASXL1 在调节 BMSCs 的干性方面发挥作用。重要的是,ASXL1 的重新引入可使 NANOG 和 OCT4 的表达正常化,并恢复 Asxl1(-/-) BMSCs 的自我更新能力。本研究揭示了 ASXL1 在维持 BMSC 功能和骨骼发育中的关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd37/4911496/db4059f853a9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd37/4911496/3fec8c346bd5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd37/4911496/521dff53e5d5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd37/4911496/d9b7fffddb56/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd37/4911496/db4059f853a9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd37/4911496/3fec8c346bd5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd37/4911496/521dff53e5d5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd37/4911496/d9b7fffddb56/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd37/4911496/db4059f853a9/gr3.jpg

相似文献

1
Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice.Asxl1 缺失改变骨髓基质细胞的自我更新和细胞命运,导致小鼠出现 Bohring-Opitz 样综合征。
Stem Cell Reports. 2016 Jun 14;6(6):914-925. doi: 10.1016/j.stemcr.2016.04.013. Epub 2016 May 26.
2
Screening of CD96 and ASXL1 in 11 patients with Opitz C or Bohring-Opitz syndromes.对11例患有Opitz C综合征或Bohring-Opitz综合征患者的CD96和ASXL1进行筛查。
Am J Med Genet A. 2016 Jan;170A(1):24-31. doi: 10.1002/ajmg.a.37418. Epub 2015 Oct 7.
3
Pathological ASXL1 Mutations and Protein Variants Impair Neural Crest Development.ASXL1 基因突变和蛋白变异导致神经嵴发育障碍。
Stem Cell Reports. 2019 May 14;12(5):861-868. doi: 10.1016/j.stemcr.2019.03.006. Epub 2019 Apr 18.
4
De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome.ASXL1 中的从头突变导致 Bohring-Opitz 综合征。
Nat Genet. 2011 Jun 26;43(8):729-31. doi: 10.1038/ng.868.
5
Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance.伴有ASXL1突变和博林-奥皮茨综合征患者的临床管理,强调对肾母细胞瘤进行监测的必要性。
Am J Med Genet A. 2015 Sep;167A(9):2122-31. doi: 10.1002/ajmg.a.37131. Epub 2015 Apr 29.
6
Bohring-Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome.伴有ASXL1新致病变异的博林-奥皮茨综合征(BOS):该综合征最常见分子和表型特征综述
Am J Med Genet A. 2015 Dec;167A(12):3161-6. doi: 10.1002/ajmg.a.37342. Epub 2015 Sep 14.
7
Matrix remodeling associated 7 promotes differentiation of bone marrow mesenchymal stem cells toward osteoblasts.基质重塑相关蛋白 7 促进骨髓间充质干细胞向成骨细胞分化。
J Cell Physiol. 2019 Aug;234(10):18053-18064. doi: 10.1002/jcp.28438. Epub 2019 Mar 6.
8
Novel truncating mutations in ASXL1 identified in two boys with Bohring-Opitz syndrome.两个患有 Bohring-Opitz 综合征的男孩中发现 ASXL1 的新型截短突变。
Eur J Med Genet. 2021 Mar;64(3):104155. doi: 10.1016/j.ejmg.2021.104155. Epub 2021 Jan 30.
9
Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.Asxl1 缺失导致小鼠出现骨髓增生异常综合征样疾病。
Blood. 2014 Jan 23;123(4):541-53. doi: 10.1182/blood-2013-05-500272. Epub 2013 Nov 19.
10
Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex.癌症相关的ASXL1突变可能作为ASXL1-BAP1复合物的功能获得性突变。
Nat Commun. 2015 Jun 22;6:7307. doi: 10.1038/ncomms8307.

引用本文的文献

1
ASXL2 Modulates Chromatin Remodeling to Direct Osteogenesis and Multiple Cell Fate in hPDLSCs.ASXL2调节染色质重塑以指导人牙周膜干细胞的成骨和多种细胞命运。
Int Dent J. 2025 Jul 17;75(5):100900. doi: 10.1016/j.identj.2025.100900.
2
Targeted disruption of PRC1.1 complex enhances bone remodeling.PRC1.1复合物的靶向破坏增强了骨重塑。
Nat Commun. 2025 May 8;16(1):4294. doi: 10.1038/s41467-025-59638-w.
3
Generation and Characterization of Induced Pluripotent Stem Cells Carrying An ASXL1 Mutation.携带 ASXL1 突变的诱导多能干细胞的生成和特征。

本文引用的文献

1
Epigenetic memory gained by priming with osteogenic induction medium improves osteogenesis and other properties of mesenchymal stem cells.通过用成骨诱导培养基预处理获得的表观遗传记忆可改善间充质干细胞的成骨能力和其他特性。
Sci Rep. 2015 Jun 8;5:11056. doi: 10.1038/srep11056.
2
Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance.伴有ASXL1突变和博林-奥皮茨综合征患者的临床管理,强调对肾母细胞瘤进行监测的必要性。
Am J Med Genet A. 2015 Sep;167A(9):2122-31. doi: 10.1002/ajmg.a.37131. Epub 2015 Apr 29.
3
Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential.
Stem Cell Rev Rep. 2024 Oct;20(7):1889-1901. doi: 10.1007/s12015-024-10737-z. Epub 2024 Jun 17.
4
Rapid progression of myelofibrosis in polycythemia vera patient carrying SRSF2 c.284C>A p.(Pro95His) and unique ASXL1 splice site c.1720-2A>G variant.携带 SRSF2 c.284C>A p.(Pro95His) 和独特的 ASXL1 剪接位点 c.1720-2A>G 变异的真性红细胞增多症患者骨髓纤维化的快速进展。
J Clin Lab Anal. 2022 May;36(5):e24388. doi: 10.1002/jcla.24388. Epub 2022 Apr 18.
5
A Variant of Is Associated With an Atypical Phenotype of Bohring-Opitz Syndrome: Case Report and Literature Review.一种与博林-奥皮茨综合征非典型表型相关的变异:病例报告及文献综述。
Front Pediatr. 2021 Aug 30;9:678615. doi: 10.3389/fped.2021.678615. eCollection 2021.
6
RNF213 gene silencing upregulates transforming growth factor β1 expression in bone marrow-derived mesenchymal stem cells and is involved in the onset of Moyamoya disease.RNF213基因沉默上调骨髓间充质干细胞中转化生长因子β1的表达,并参与烟雾病的发病过程。
Exp Ther Med. 2021 Sep;22(3):1024. doi: 10.3892/etm.2021.10456. Epub 2021 Jul 15.
7
IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway.IGF-1 通过分泌卷曲相关蛋白 2 通路增强骨髓间充质干细胞在心肌梗死中的活力、迁移和抗凋亡作用。
Stem Cell Res Ther. 2020 Jan 9;11(1):22. doi: 10.1186/s13287-019-1544-y.
8
A truncating mutation in associated with segmental overgrowth.与节段性过度生长相关的一种截断突变。
J Genet. 2019 Dec;98. doi: 10.1007/s12041-019-1155-5.
9
H₂O₂ Damages the Stemness of Rat Bone Marrow-Derived Mesenchymal Stem Cells: Developing a "Stemness Loss" Model.H₂O₂ 损伤大鼠骨髓间充质干细胞的干性:建立“干性丧失”模型。
Med Sci Monit. 2019 Jul 29;25:5613-5620. doi: 10.12659/MSM.914011.
10
Loss of ASXL1 in the bone marrow niche dysregulates hematopoietic stem and progenitor cell fates.骨髓微环境中ASXL1的缺失会失调造血干细胞和祖细胞的命运。
Cell Discov. 2018 Jan 23;4:4. doi: 10.1038/s41421-017-0004-z. eCollection 2018.
Gremlin 1可识别一种具有形成骨、软骨和网状基质潜能的骨骼干细胞。
Cell. 2015 Jan 15;160(1-2):269-84. doi: 10.1016/j.cell.2014.11.042.
4
Enrichment Map - a Cytoscape app to visualize and explore OMICs pathway enrichment results.富集图 - 一款用于可视化和探索组学通路富集结果的Cytoscape应用程序。
F1000Res. 2014 Jul 1;3:141. doi: 10.12688/f1000research.4536.1. eCollection 2014.
5
Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow.表达瘦素受体的间充质基质细胞是成年骨髓形成骨骼的主要来源。
Cell Stem Cell. 2014 Aug 7;15(2):154-68. doi: 10.1016/j.stem.2014.06.008. Epub 2014 Jun 19.
6
Metabolic requirements for the maintenance of self-renewing stem cells.维持自我更新干细胞的代谢需求。
Nat Rev Mol Cell Biol. 2014 Apr;15(4):243-56. doi: 10.1038/nrm3772.
7
Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.Asxl1 缺失导致小鼠出现骨髓增生异常综合征样疾病。
Blood. 2014 Jan 23;123(4):541-53. doi: 10.1182/blood-2013-05-500272. Epub 2013 Nov 19.
8
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo.Asxl1 缺失导致骨髓增生异常和体内严重的发育缺陷。
J Exp Med. 2013 Nov 18;210(12):2641-59. doi: 10.1084/jem.20131141. Epub 2013 Nov 11.
9
Mesenchymal stem cells in joint disease and repair.关节疾病与修复中的间充质干细胞。
Nat Rev Rheumatol. 2013 Oct;9(10):584-94. doi: 10.1038/nrrheum.2013.109. Epub 2013 Jul 23.
10
PDGFRα and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion.PDGFRα 和 CD51 标记人类巢蛋白+球体形成间充质干细胞,能够扩增造血祖细胞。
J Exp Med. 2013 Jul 1;210(7):1351-67. doi: 10.1084/jem.20122252. Epub 2013 Jun 17.